Peptira
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Peptira between 22 Feb 2026 and 9 Jul 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Peptira
Retatrutide
Tested 4 Samples
Last test 9 Jul 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Peptira
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
9 Jul 2026
First
22 Feb 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 9 Jul 2026 | View | 10mg | (no batch claim) | 10.9mg | +9.0% | 99.40% | n/a | March 5, 2026 | No label / Silver crimp / Black cap | Lab G | Public | |
| 8 May 2026 | View | 10mg | (no batch claim) | 6.16mg | -38.4% | 99.90% | n/a | RETA10-004 | Silver Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 23 Apr 2026 | View | 30mg | 32.2mg | 30mg | -6.8% | 99.90% | below LOQ | RETA30-008 | Silver Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 22 Feb 2026 | View | 30mg | 32.2mg | 31.9mg | -0.9% | 98.44% | n/a | Reta30-008 | Gray Label / Silver Crimp / Pink Cap | Lab E | Public | |